健民集团 (600976)

Jianmin Pharmaceutical Group Co., Ltd.

ASH

Tags

SSE 580 IndexTraditional Chinese MedicineInnovative DrugsPharmaceuticals and HealthcareInfant and Child ConceptWholesaleNew Private Equity HoldingsHigh-Performing StocksMargin Trading and Securities Lending医药生物中药Ⅱ

K-Line Chart

No K-line data available

Company NameJianmin Pharmaceutical Group Co., Ltd.
Listing Date2004-04-19
Issue Price11.6RMB
Registered Capital15339.8610k RMB
Legal RepresentativeWang Jun
Registered AddressNo. 484 Yingwu Avenue, Hanyang District, Wuhan City, Hubei Province
IndustryTraditional Chinese Medicine II
Main BusinessResearch and development, manufacturing, wholesale, and retail of pharmaceuticals.
Company ProfileJianmin Pharmaceutical Group Co., Ltd. focuses on the development of traditional Chinese medicine (TCM), with pediatric products as its specialty. It has become a key national TCM enterprise and a production base for pediatric medications. The company is a time-honored Chinese brand, owning three major brands: "Jianmin", "Longmu", and "Yekaitai". Its comprehensive strength ranks among the top 100 pharmaceutical enterprises in China. It has established a corporate postdoctoral research workstation and a Children's Drug Research Institute. Its leading product, Longmu Zhuanggu Granules, is a first-class TCM protected variety and a well-known brand in the field of children's health and growth medications.

Stock Details

1. Key Indicators

  • Total Shares(W): 15339.86
  • Circulating A-Shares(W): 15329.86
  • Earnings Per Share(RMB): 1.8800
  • Net Assets Per Share(RMB): 16.8339
  • Operating Revenue(W RMB): 255193.42
  • Total Profit(W RMB): 30575.68
  • **Net Profit Attributable to Parent(W RMB) **: 28573.73
  • Net Profit Growth Rate(%): -11.16
  • Weighted Return on Equity(%): 11.4200
  • Operating Cash Flow Per Share(RMB): 0.9070
  • Undistributed Profit Per Share(RMB): 11.4703
  • Capital Reserve Per Share(RMB): 3.4077

2. Main Business

The main business covers:

  • Research, development, manufacturing, wholesale and retail of pharmaceuticals

3. Company Basic Information

  • Company Name: Jianmin Pharmaceutical Group Co., Ltd.
  • Listing Date: 2004-04-19
  • Industry: Pharmaceuticals and Healthcare - Traditional Chinese Medicine
  • Address: No. 484 Yingwu Avenue, Hanyang District, Wuhan City, Hubei Province
  • Website: https://www.whjm.com/
  • Company Profile: The company's predecessor, Wuhan Jianmin Pharmaceutical Factory, was established on June 1, 1953. It was formed on the basis of Ye Kai Tai Ginseng Drug Store, one of China's oldest four major traditional Chinese medicine stores with a history of over 360 years. On March 18, 1993, approved by the Wuhan Economic System Reform Committee, the company was established through a directional placement by the Wuhan Jianmin Pharmaceutical Factory as the main sponsor, jointly initiated by China National Medicines Corporation and China National Pharmaceutical Group Co., Ltd. On May 28, 1993, after the capital contributions from the three sponsors and four directional placement corporate shareholders were received, the company completed the industrial and commercial registration procedures with the Wuhan Administration for Industry and Commerce, with an initial registered capital of 34.659 million yuan.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Huali Pharmaceutical Group Co., Ltd. General Legal Person 3701.41 24.15
2 Hong Kong Securities Clearing Company Ltd. Northbound Capital 706.35 4.61
3 Huali Group Co., Ltd. General Legal Person 509.85 3.33
4 Rongtong Health Industry Flexible Allocation Mixed Securities Investment Fund Class A Fund 140.00 0.91
5 Ping An Anying Stock Pension Product - Bank of China Co., Ltd. General Legal Person 132.97 0.87
6 China National Pharmaceutical Group Co., Ltd. General Legal Person 132.35 0.86
7 Shanghai Liuhe Zhiqian Private Fund Management Center (Limited Partnership) - Liuhe Qianheng Private Securities Investment Fund Private Securities Investment Fund 129.42 0.84
8 Galaxy Pharmaceutical Health Mixed Securities Investment Fund Class A Fund 89.81 0.59
9 Galaxy Kangle Stock Securities Investment Fund Class A Fund 23.97 0.16
10 Xiangcai Pharmaceutical Health Mixed Securities Investment Fund Class A Fund 15.27 0.10

5. Concept Sectors

  • Child Concept
  • Innovative Drugs
  • Margin Trading & Securities Lending
  • High-Performance Stocks
  • Potential for Bonus Shares & Splits
  • New Private Placements
  • SSE 580

Remarks

  • Data update date: 2025-09-30
  • Data source: Public Market Information